Related Experiment Video
Updated: Jul 16, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Prostate Cancer Treatment: Cryoablation in Context
Thomas Lilieholm1, Michael C Risk2, David Jarrard2
1Department of Medical Physics, University of Wisconsin-Madison, Madison, WI 53705, USA.
Cancers
|July 15, 2026
Summary
Focal cryoablation is an effective and well-tolerated treatment for prostate cancer (PCa), offering a minimally invasive option for primary and recurrent cases. Further long-term studies are needed to fully establish its benefits and standardize outcomes.
Area of Science:
- Oncology
- Urology
- Minimally Invasive Surgery
Background:
- Prostate cancer (PCa) is a common malignancy in men, with current research focusing on treatments that improve quality of life.
- Focal cryoablation is emerging as a promising treatment due to its reduced morbidity and potential for salvage therapy.
Purpose of the Study:
- To discuss the safety and efficacy of focal cryoablation for prostate cancer.
- To contextualize focal cryoablation within existing treatment modalities.
Main Methods:
- A review and collation of publications on prostate cancer cryoablation.
- Comparative analysis against radiation, surgery, hormone therapy, and other ablation techniques.
Main Results:
- Prostate cryoablation is characterized as effective and well-tolerated for primary and recurrent PCa.
- Current data are limited by heterogeneous evidence, lack of standardized endpoints, and few randomized trials.
Conclusions:
- Focal cryoablation is an evolving, minimally invasive option for prostate cancer patients.
- Additional long-term studies are necessary to validate its efficacy and standardize its application.
